Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype. (Q41954383)
Jump to navigation
Jump to search
scientific article published on September 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype. |
scientific article published on September 1989 |
Statements
Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype (English)
L F Gram
K Brøsen
P Kragh-Sørensen
1 September 1989